Position in PRME
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,657,031
+$867,071 QoQ
Shares Held
449,060
+97.8% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#35
of 186 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in PRME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHELSEA COUNSEL CO holds $1,741,341 across 4 Biotechnology names. PRME ranks #1 (95.2% of the industry book) .
All Filings in PRME
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,657,031 | 449,060 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $789,960 | 227,000 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $787,690 | 227,000 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $1,153,483 | 208,210 | Shares | Sole | 2025-11-25 | |
| 2025-06-30 | $514,278 | 208,210 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $414,337 | 208,210 | Shares | Sole | 2025-05-22 | |
| 2024-12-31 | $545,397 | 186,780 | Shares | Sole | 2025-02-27 | |
| 2024-09-30 | $304,530 | 78,690 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $399,326 | 77,690 | Shares | Sole | 2024-11-21 | |
| 2024-03-31 | $35,000 | 5,000 | Shares | Sole | 2024-06-17 | |
| 2023-12-31 | $44,300 | 5,000 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $5,724 | 600 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $8,790 | 600 | Shares | Sole | 2023-11-22 | |
| 2023-03-31 | $7,380 | 600 | Shares | Sole | 2023-05-19 | |
| 2022-12-31 | $11,148 | 600 | Shares | Sole | 2023-02-23 | |
| No filing history on record for this holder in this stock. | ||||||